Vasoactive intestinal peptide and substance P in salivary glands of the rat following denervation or duct ligation.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 6085176)

Published in Regul Pept on December 01, 1984

Authors

J Ekström, E Brodin, R Ekman, R Håkanson, F Sundler

Articles by these authors

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25

The Lidköping Accident Prevention Programme--a community approach to preventing childhood injuries in Sweden. Inj Prev (1995) 3.09

Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom (1999) 3.05

A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A (1983) 2.64

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46

Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45

Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27

School accidents during a three school-years period in a Swedish municipality. Public Health (1991) 2.15

Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci (2000) 2.12

Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept (1986) 2.05

Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology (1983) 1.90

Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med (1997) 1.84

The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept (2002) 1.82

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol (1988) 1.77

A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76

Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74

Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71

Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience (1978) 1.67

Making sense of safety. Inj Prev (2004) 1.63

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci (1994) 1.61

Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut (2004) 1.59

Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry (1986) 1.57

Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol (1979) 1.54

Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52

Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol (2001) 1.51

Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. Acta Physiol Scand (1983) 1.51

Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem (2004) 1.47

Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clin Endocrinol (Oxf) (1996) 1.46

Prompt epithelial damage and restitution processes in allergen challenged guinea-pig trachea in vivo. Clin Exp Allergy (1997) 1.46

Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol (1984) 1.46

In vivo restitution of airway epithelium. Cell Tissue Res (1995) 1.43

Endogenous hypergastrinaemia does not promote growth of colonic mucosa or of a transplanted colon adenocarcinoma in rats. Eur J Gastroenterol Hepatol (1998) 1.42

Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41

Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39

S-enantiomer of the selective serotonin reuptake inhibitor citalopram compared with racemate citalopram (S+R). Pharmacol Toxicol (2001) 1.39

Elevated CSF somatostatin concentrations in demented patients parallel improved psychomotor functions induced by integrity-promoting care. Acta Psychiatr Scand (1989) 1.38

[How reliable is the laboratory? Increased needs of patient-related quality assurance]. Lakartidningen (1999) 1.38

Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig. Acta Physiol Scand (1984) 1.38

Motor responses in rat ileum evoked by nitric oxide donors vs. field stimulation: modulation by pituitary adenylate cyclase-activating peptide, forskolin and guanylate cyclase inhibitors. J Pharmacol Exp Ther (1997) 1.36

Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept (1985) 1.35

The role of endogenous gastrin in the activation of gastric histidine decarboxylase in the rat. Effect of antrectomy and vagal denervation. Eur J Pharmacol (1970) 1.34

Blood glucose measurement with Dextrostix and new reflectance meter. Br Med J (1974) 1.34

Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther (1985) 1.34

Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med (1999) 1.34

Substance P: release on trigeminal nerve stimulation, effects in the eye. Acta Physiol Scand (1979) 1.33

Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol (1998) 1.33

Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A (1994) 1.33

Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32

Peptidergic (substance P) nerves in the genito-urinary tract. Neuroscience (1978) 1.31

Release of substance P-like immunoreactivity from the dental pulp. Acta Physiol Scand (1977) 1.30

Cellular localization of histamine and monoamines in the gastric mucosa of man. Histochemie (1969) 1.30

Peptidergic (enkephalin) innervation of the mammalian esophagus. Gastroenterology (1980) 1.27

Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27

Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology (1988) 1.27

Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol (1974) 1.27

Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res (1987) 1.27

Fluorometric determination of histamine with OPT: optimum reaction conditions and tests of identity. Anal Biochem (1972) 1.27

Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry (1975) 1.27

A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept (2001) 1.26

Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab (1987) 1.26

Unintentional home-related injuries in the Islamic Republic of Iran: findings from the first year of a national programme. Public Health (2005) 1.26

Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept (1984) 1.26

The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol (1988) 1.25

Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology (1983) 1.25

Substance P- and CGRP-immunoreactive nerves in bone. Peptides (1988) 1.24

Peptide-containing nerve fibers in the stomach wall of rat and mouse. Gastroenterology (1985) 1.23

Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23

Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept (1986) 1.22

Concomitant histochemical demonstration of histamine and catecholamines in enterochromaffin-like cells of gastric mucosa. Life Sci (1967) 1.22

Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci (1998) 1.21

A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science (1981) 1.20

Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20

Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tissue Res (1977) 1.20

Duodenal endocrine cells in adult coeliac disease. Gut (1979) 1.19